Back to All Events

Best of Breast

Virtual Access Only | 5.00 CE/CME Credits & MOC Points

The Best of Breast Conference will take place on February 22, 2025. This innovative and state of the art program is set in a multidisciplinary tumor board environment featuring some of the world's leading breast cancer experts to discuss cases beginning with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care, and survivorship and recurrence—all while incorporating data from the major oncologic annual meetings.

 

Conference Agenda
Saturday, February 22, 2025

8:00 AM
Welcome and Exhibits

8:30 AM
Program Chair Opening Remarks

8:35 AMCDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Latest Advances
Early Stage ER+ Case Reshma Mahtani, DO | Miami Cancer Institute  Joseph Panoff, MD | Miami Cancer Institute  Taiwo Adesoye, MD, MPH | MD Anderson Cancer Center 

9:35 AM
Break and Exhibits

9:50 AM
Early Stage Triple Negative Case Neil Iyengar, MD | Memorial Sloan Kettering Cancer Center  Sunil Badve, MD, FRCPath | Emory Winship Cancer Institute  Taiwo Adesoye, MD, MPH | MD Anderson Cancer Center 

10:50 AM
Break and Exhibits

11:05 AM
Non-CME Session

11:50 AM
Break and Exhibits

12:05 PM
Metastatic ER+ Case Reshma Mahtani, DO | Miami Cancer Institute  Ashwin Mehta, MD | Memorial Healthcare System 

1:05 PM
Her2 Positive Case Neil Iyengar, MD | Memorial Sloan Kettering Cancer Center  Joseph Panoff, MD | Miami Cancer Institute  Sunil Badve, MD, FRCPath | Emory Winship Cancer Institute 

2:05 PM
Break and Exhibits

2:20 PM
Non-CME Session

3:05 PM
Break and Exhibits

3:20 PM
Supportive Care and Symptom Management

3:50 PM
Integrative Medicine Ashwin Mehta, MD | Memorial Healthcare System

4:20 PM
Legends Ceremony

4:35 PM
Wine Networking Reception

Agenda Subject To Change. All times are EST.

 
    • Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various breast cancers.

    • Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with breast cancer.

    • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with breast cancer.

  • In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nurses (ANCC) Credit Designation

    Amedco LLC designates this activity for a maximum of 5.00 ANCC contact hours.

    Physicians (ACCME) Credit Designation

    Amedco LLC designates this live activity for a maximum of 5.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

    Amedco LLC designates this activity for a maximum of 5.00 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

    • Free registration for all healthcare providers

    • Expert sessions that present the most clinically relevant data, research, and clinical strategies

    • Real-time discussion and debate

    • Networking with peers, colleagues, and medical professionals

    • Access to the latest industry information and resources

 
Previous
Previous
February 8

West Oncology Conference

Next
Next
February 27

Cancer Updates GI and Breast